Option Care HealthOPCH
OPCH
0
Funds holding %
of 6,780 funds
0
Analysts bullish %
of 6 analysts
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
50% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 3 (+1) [Q3]
34% more call options, than puts
Call options by funds: $4.84M | Put options by funds: $3.61M
8% more capital invested
Capital invested by funds: $4.9B [Q2] → $5.32B (+$415M) [Q3]
3% less repeat investments, than reductions
Existing positions increased: 118 | Existing positions reduced: 122
2% less funds holding
Funds holding: 341 [Q2] → 333 (-8) [Q3]
2.44% less ownership
Funds ownership: 101.8% [Q2] → 99.36% (-2.44%) [Q3]
14% less first-time investments, than exits
New positions opened: 49 | Existing positions closed: 57
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$26
9%
upside
Avg. target
$33
37%
upside
High target
$40
67%
upside
6 analyst ratings
4 positive
67%
2 neutral
33%
0 negative
0%
Goldman Sachs Jamie Perse 56% 1-year accuracy 5 / 9 met price target | 13%upside $27 | Neutral Downgraded | 5 Nov 2024 |
Truist Securities David Macdonald 60% 1-year accuracy 25 / 42 met price target | 42%upside $34 | Buy Maintained | 1 Nov 2024 |
Barrington Research Michael Petusky 63% 1-year accuracy 22 / 35 met price target | 34%upside $32 | Outperform Maintained | 31 Oct 2024 |
Jefferies Brian Tanquilut 70% 1-year accuracy 7 / 10 met price target | 9%upside $26 | Hold Downgraded | 31 Oct 2024 |
Barrington Research Michael Petusky 63% 1-year accuracy 22 / 35 met price target | 67%upside $40 | Outperform Maintained | 23 Oct 2024 |
Financial journalist opinion
Neutral
Seeking Alpha
1 month ago
Option Care Health, Inc. (OPCH) Q3 2024 Earnings Call Transcript
Option Care Health, Inc. (NASDAQ:OPCH ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Nicole Maggio – Senior Vice President-Finance John Rademacher – President and Chief Executive Officer Mike Shapiro – Chief Financial Officer Conference Call Participants David MacDonald – Truist Constantine Davides – Citizens JMP Securities Lisa Gill – JPMorgan Matt Larew – William Blair Brian Tanquilut – Jefferies Jamie Perse – Goldman Sachs Pito Chickering – Deutsche Bank Joanna Gajuk – Bank of America Operator Good day and thank you for standing by. Welcome to the Option Care Health Third Quarter 2024 Earnings Conference Call.
Positive
Zacks Investment Research
1 month ago
Option Care (OPCH) Surpasses Q3 Earnings and Revenue Estimates
Option Care (OPCH) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.31 per share a year ago.
Neutral
GlobeNewsWire
1 month ago
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2024
BANNOCKBURN, Ill., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2024.
Positive
Kiplinger
1 month ago
The Best Growth Stocks to Buy
Growth stocks can create significant returns for investors, but what are they and how do you find the best ones? We take a closer look here.
Neutral
GlobeNewsWire
2 months ago
Option Care Health to Announce Third Quarter 2024 Financial Results and Host Conference Call
BANNOCKBURN, Ill., Oct. 02, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2024 on Wednesday, October 30, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
Neutral
Zacks Investment Research
4 months ago
OPCH vs. ASTH: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Astrana Health, Inc. (ASTH). But which of these two stocks offers value investors a better bang for their buck right now?
Positive
Zacks Investment Research
4 months ago
Wall Street Analysts Predict a 31.8% Upside in Option Care (OPCH): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 31.8% in Option Care (OPCH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Positive
Zacks Investment Research
4 months ago
Should Value Investors Buy Option Care Health (OPCH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
Seeking Alpha
4 months ago
Option Care Health, Inc. (OPCH) Q2 2024 Earnings Call Transcript
Option Care Health, Inc. (NASDAQ:OPCH ) Q2 2024 Earnings Conference Call July 31, 2024 8:30 AM ET Company Participants Nicole Maggio - Senior Vice President of Finance John Rademacher - President & CEO Mike Shapiro - CFO Conference Call Participants Lisa Gill - JPMorgan Constantine Davides - Citizens JMP Matt Larew - William Blair David MacDonald - Truist Securities Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Michael Petusky - Barrington Research Operator Good day, and thank you for standing by. Welcome to the Option Care Health Second Quarter 2024 Earnings Conference Call.
Positive
Zacks Investment Research
4 months ago
Option Care (OPCH) Q2 Earnings and Revenues Top Estimates
Option Care (OPCH) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.63 per share a year ago.
Charts implemented using Lightweight Charts™